COMPASS Pathways Plc American Depository Shares Company Profile
NASDAQ: CMPSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
COMPASS Pathways Plc American Depository Shares at a glance
COMPASS Pathways Plc American Depository Shares (NASDAQ: CMPS) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in London, United Kingdom. COMPASS Pathways Plc American Depository Shares is led by Mr. Kabir Kumar Nath M.A., M.B.A. and employs about 156 people. The company's shares have traded publicly since 2020.
At a market capitalization of $1.60 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001816590, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does COMPASS Pathways Plc American Depository Shares do?
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Business description based on the company's public filings.
Company information
- Legal name
- COMPASS Pathways Plc American Depository Shares
- Ticker
- NASDAQ: CMPS
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Kabir Kumar Nath M.A., M.B.A.
- Employees
- 156
- Headquarters
- 33 Broadwick Street, London, United Kingdom
- Phone
- 44 716 6766461
- Website
- compasspathways.com
- IPO year
- 2020
- Market cap
- $1.60B
- SEC CIK
- 0001816590
Companies similar to COMPASS Pathways Plc American Depository Shares
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| QUREuniQure N.V. | 23.14 | +0.35% | $1.61B | vs CMPS |
| OCULOcular Therapeutix Inc. | 7.23 | -1.50% | $1.59B | vs CMPS |
| ETONEton Pharmaceuticals Inc. | 54.88 | +0.20% | $1.57B | vs CMPS |
| STOKStoke Therapeutics Inc. | 24.29 | -0.33% | $1.57B | vs CMPS |
| ANIPANI Pharmaceuticals Inc. | 71.93 | +0.57% | $1.65B | vs CMPS |
| PAHCPhibro Animal Health Corporation Class A | 37.72 | +3.03% | $1.53B | vs CMPS |
| BRVEBraveheart Bio Inc. | 18.58 | -6.11% | $1.67B | vs CMPS |
| INVAInnoviva Inc. | 21.06 | +1.10% | $1.52B | vs CMPS |